Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Switches in food and beverage product purchases can reduce greenhouse gas emissions in Australia

    Switching between similar food and beverage products may reduce greenhouse gas emissions (GHGe). Here, using consumer data linked to 23,550 product-specific GHGe values, we estimated annual GHGe attributable t...

    Allison Gaines, Maria Shahid, Daisy Coyle, Eden Barrett, Michalis Hadjikakou in Nature Food (2024)

  2. Article

    Open Access

    The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants

    Headache is one of the most common neurological symptoms. Headache disorders are associated with a high global burden of disease. Prior studies indicate that short-to-medium term sodium reduction reduces heada...

    Faraidoon Haghdoost, Sonali R. Gnanenthiran in European Journal of Clinical Nutrition (2024)

  3. Article

    Open Access

    The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study

    The Salt Substitute and Stroke Study (SSaSS) demonstrated significant reductions in systolic blood pressure (SBP), and the risk of stroke, major cardiovascular events and total mortality with the use of potass...

    Li** Huang, Qiang Li, Jason HY Wu, Maoyi Tian in Journal of Human Hypertension (2024)

  4. Article

    Open Access

    Factors influencing the time to ethics and governance approvals for clinical trials: a retrospective cross-sectional survey

    The findings from multi-centre trials are central to the practice of evidence-based medicine, enabling the development and implementation of new treatments. The time it takes to commence clinical trials at sit...

    Sam Crosby, Adriana Malavisi, Li** Huang, Stephen Jan, Richard Holden in Trials (2023)

  5. Article

    Open Access

    Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia

    To assess any effects of a state-wide sodium reduction intervention on sodium intake, sources of dietary sodium and discretionary salt use at a population level.

    Kristy A. Bolton, Joseph Alvin Santos, Emalie Rosewarne in European Journal of Nutrition (2023)

  6. Article

    Open Access

    Changes in sodium levels in Australian packaged foods between 2014 and 2019: an interrupted time series analysis of the impact of the Victorian Salt Reduction Partnership’s media advocacy strategy

    The Victorian Salt Reduction Partnership (VSRP) implemented a media advocacy strategy (intervention) to stimulate food manufacturers to reduce sodium levels across targeted Australian packaged foods between 20...

    Emalie Rosewarne, Joseph Alvin Santos in International Journal of Behavioral Nutrit… (2023)

  7. Article

    Open Access

    2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

    Norm R. C. Campbell, Paul K. Whelton, Marcelo Orias in Journal of Human Hypertension (2023)

  8. Article

    Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial

    There is a paucity of high-quality evidence on the effectiveness and safety of salt reduction strategies, particularly for older people, who have the most to benefit but are at higher risk of adverse effects. ...

    Yifang Yuan, Aoming **, Bruce Neal, **angxian Feng, Qianku Qiao in Nature Medicine (2023)

  9. Article

    Open Access

    Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel

    Consumption of ultra-processed foods is associated with increased risk of obesity and non-communicable diseases. Little is known about current patterns of ultra-processed foods intake in Australia. The aim of ...

    Daisy H. Coyle, Li** Huang, Maria Shahid in International Journal of Behavioral Nutrit… (2022)

  10. Article

    Open Access

    Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial

    Enhanced de-novo collagen type VI (COL VI) formation has been associated with kidney and cardiovascular fibrosis. We hypothesized that endotrophin (ETP), a product specifically generated during collagen type V...

    Daniel Guldager Kring Rasmussen, Michael K. Hansen in Cardiovascular Diabetology (2022)

  11. Article

    Open Access

    Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

    Sodium glucose co-transporter-2 (SGLT2) inhibitors reduce the risk of kidney and heart failure events independent of glycemic effects. We assessed whether initiation of the SGLT2 inhibitor canagliflozin guided...

    Sok Cin Tye, Niels Jongs, Steven G. Coca, Johan Sundström in Cardiovascular Diabetology (2022)

  12. Article

    Open Access

    The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review

    Governments have attempted to increase clinical trial activity in their jurisdictions using a range of methods including simplifying the ethics review and governance process of clinical trials. This study’s ob...

    Sam Crosby, Esther Rajadurai, Stephen Jan in Humanities and Social Sciences Communicati… (2022)

  13. Article

    Open Access

    Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm

    Multiple observational studies have associated metformin prescription with reduced progression of abdominal aortic aneurysm (AAA). The Metformin Aneurysm Trial (MAT) will test whether metformin reduces the ris...

    Jonathan Golledge, Clare Arnott, Joseph Moxon, Helen Monaghan, Richard Norman in Trials (2021)

  14. Article

    Open Access

    Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program

    Type 2 diabetes mellitus can manifest over a broad clinical range, although there is no clear consensus on the categorisation of disease complexity. We assessed the effects of canagliflozin, compared with plac...

    Tamara K. Young, **g-Wei Li, Amy Kang, Hiddo J. L. Heerspink in Diabetologia (2021)

  15. No Access

    Article

    The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials

    Sodium and potassium appear to interact with each other in their effects on blood pressure with potassium supplementation having a greater blood pressure lowering-effect when sodium intake is high. Whether the...

    Li** Huang, Bruce Neal, Jason H. Y. Wu, Yuli Huang in Journal of Human Hypertension (2021)

  16. Article

    Open Access

    Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases

    Countries around the world are putting in place sugar reformulation targets for packaged foods to reduce excess sugar consumption. The Australian government released its voluntary sugar reformulation targets f...

    Daisy H. Coyle, Maria Shahid in International Journal of Behavioral Nutrit… (2021)

  17. Article

    Open Access

    Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial

    Higher plasma concentrations of tumour necrosis factor receptor (TNFR)-1, TNFR-2 and kidney injury molecule-1 (KIM-1) have been found to be associated with higher risk of kidney failure in individuals with typ...

    Taha Sen, **gwei Li, Brendon L. Neuen, Bruce Neal, Clare Arnott in Diabetologia (2021)

  18. Article

    Open Access

    Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease

    Consumption of nuts improves cardio-metabolic risk factors in clinical trials and relates to lower risk of cardiovascular disease (CVD) in prospective observational studies. However, there has not been an adeq...

    Yishu Liu, Nan Li, Ni Yan, **ong-fei Pan, Qiang Li, Renata Micha in Nutrition Journal (2021)

  19. Article

    Open Access

    Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia

    An amendment to this paper has been published and can be accessed via the original article.

    Daisy H. Coyle, Maria Shahid in International Journal of Behavioral Nutrit… (2020)

  20. Article

    Open Access

    Contribution of major food companies and their products to household dietary sodium purchases in Australia

    The Australian federal government will soon release voluntary sodium reduction targets for 30 packaged food categories through the Healthy Food Partnership. Previous assessments of voluntary targets show varia...

    Daisy H. Coyle, Maria Shahid in International Journal of Behavioral Nutrit… (2020)

previous disabled Page of 3